A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
We are looking for people of all ages, regardless of health condition, to take part in a study that is looking for new treatments for bone and muscle disorders.Bone and muscle disorders are the leading cause of disabilty in the United States. Researchers want to find out more about how …
The purpose of this study is to track outcome measures and rehabilitation interventions performed during recovery for the first 12 months following stroke.
DID YOU KNOW?... Seizures are one of the most common reasons why people call 9-1-1 for children. Seizures that do not stop on their own can be life-threatening. Researchers at Indiana University School of Medicine are looking for children to take part in a study to identify ways help improve …
To determine the spectrum and time course of coronary artery involvement, left ventricular (LV) systolic function, and arrhythmias or conduction system disturbances within the first year from illness onset,
Children with juvenile idiopathic arthritis (JIA) can develop jaw damage when the jaw joints (temporomandibular joints or TMJ) are involved. This jaw damage can cause pain on opening, pain on chewing and jaw growth problems leading to a small jaw with trouble opening the mouth. This registry would collect data …
We are investigating the use of a painless ultrasound technology called Transient Elastography (TE) to measure changes in the liver that indicate the amount of scar tissue in the liver. Ultrasound technology works by placing a probe on the outside of your body, which uses sound waves to create a …
The purpose of this collaborative CTSA application is to develop an innovative perioperativegesia platform (PPAP) to improve analgesia and reduce serious immediate andg-term adverse outcomes of perioperative opioids in children undergoing painful surgery.
The purpose of this study is to measure improvements in liver fibrosis and inflammation with GSK4532990 compared with placebo in participants with NASH and advanced (F3) fibrosis. Theudy duration will be up to 76 weeks including the screening period. The treatment duration will be up to 52 weeks.